Portfolio Companies News
April 18, 2019BONESUPPORT HOLDING AB (publ) publi...
BONESUPPORTs annual report for 2018 is now available as a pdf on the group’s web page, www.bonesupport.com. A PDF-version is also attached to this press release. About BONESUPPORT™ BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative inj... read more
April 17, 2019GenSight Biologics reports positive...
GS010-treated eyes showed continuous recovery of visual functions from nadir (worst vision post-treatment) in both best-corrected visual acuity (BCVA) and contrast sensitivity (CS) GS010-treated eyes recovered 21 ETDRS letters from nadir at Week 72 Bilateral improvements in visual function... read more
April 16, 2019Aprea Therapeutics Receives FDA Fas...
April 16, 2019—BOSTON, MA. and STOCKHOLM, SWEDEN, April 16, 2019 – Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced that the U.S. Food and Drug Administration (FDA) has... read more
April 15, 2019Strongbridge Biopharma plc Announce...
DUBLIN, Ireland and TREVOSE, Pa., April 15, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet nee... read more
April 12, 2019Vicore Pharma's Annual Report 2018 ...
Mölndal, April 12, 2019 - Vicore Pharma Holding AB (publ) announces today that the annual report for 2018 has been published and is available on the company's website: https://vicorepharma.com/investors/#reports The annual report shows that the publication date for the interim report quarter th... read more
February 18, 2019Q4 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 113 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.